|
Volumn 121, Issue 12, 2015, Pages 1911-1912
|
Lung cancer new leading cause of death for women in developed countries: Data reflects increased rates of smoking
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AFATINIB;
ANAPLASTIC LYMPHOMA KINASE;
ANAPLASTIC LYMPHOMA KINASE INHIBITOR;
EPIDERMAL GROWTH FACTOR RECEPTOR;
ERLOTINIB;
AIR POLLUTION CONTROL;
CANCER IMMUNOTHERAPY;
CANCER INCIDENCE;
CANCER MORTALITY;
CANCER RESISTANCE;
CANCER STAGING;
CANCER STATISTICS;
CANCER SURVIVAL;
CAUSE OF DEATH;
DEVELOPED COUNTRY;
EARLY DIAGNOSIS;
ENVIRONMENTAL FACTOR;
GENE MUTATION;
GENE REARRANGEMENT;
HEALTH CARE ACCESS;
HIGH RISK PATIENT;
HUMAN;
LUNG CANCER;
MOLECULARLY TARGETED THERAPY;
NON SMALL CELL LUNG CANCER;
NOTE;
PRIORITY JOURNAL;
PUBLIC HEALTH;
SMOKING;
SMOKING CESSATION;
SMOKING REGULATION;
SPIRAL COMPUTER ASSISTED TOMOGRAPHY;
THORAX RADIOGRAPHY;
TREND STUDY;
UNITED STATES;
WOMEN'S HEALTH;
ADVERSE EFFECTS;
EPIDEMIOLOGY;
FEMALE;
LUNG TUMOR;
MORTALITY;
STATISTICS AND NUMERICAL DATA;
CAUSE OF DEATH;
DEVELOPED COUNTRIES;
FEMALE;
HUMANS;
LUNG NEOPLASMS;
SMOKING;
|
EID: 84940706941
PISSN: 0008543X
EISSN: 10970142
Source Type: Journal
DOI: 10.1002/cncr.28995 Document Type: Note |
Times cited : (6)
|
References (1)
|